The Bcl-2 Family Antagonist ABT-737 Significantly Inhibits Multiple Animal Models of Autoimmunity-Reference-Cited by-同舟云学术

The Bcl-2 Family Antagonist ABT-737 Significantly Inhibits Multiple Animal Models of Autoimmunity

Published:2009-06-03 Issue:12 Volume:182 Page:7482-7489
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Bardwell Philip D.,Gu Jijie,McCarthy Donna,Wallace Craig,Bryant Shaughn,Goess Christian,Mathieu Suzanne,Grinnell Chris,Erickson Jamie,Rosenberg Saul H.,Schwartz Annette J.,Hugunin Margaret,Tarcsa Edit,Elmore Steven W.,McRae Bradford,Murtaza Anwar,Wang Li Chun,Ghayur Tariq

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference43 articles.

1. Control of Apoptosis in the Immune System: Bcl-2, BH3-Only Proteins and More

2. T-lymphocyte death during shutdown of an immune response

3. Apoptosis genes and autoimmunity

4. Mechanisms of Disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis

5. Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased imaging ligand hydrophilicity and improved pharmacokinetic properties provides enhanced in vivo targeting of fibroblast activation protein;npj Imaging;2024-08-02

2. Directly targeting BAX for drug discovery: Therapeutic opportunities and challenges;Acta Pharmaceutica Sinica B;2024-06

3. Unlocking the Therapeutic Potential of BCL-2 Associated Protein Family: Exploring BCL-2 Inhibitors in Cancer Therapy;Biomolecules & Therapeutics;2024-04-09

4. Increased Imaging Ligand Hydrophilicity and Improved Pharmacokinetic Properties Provides Enhanced In Vivo Targeting of Fibroblast Activation Protein;2024-04-05

5. Differential expression pattern of Bcl-2 family members in B and T cells in systemic lupus erythematosus and rheumatoid arthritis;Arthritis Research & Therapy;2023-11-22